RNAZ

TransCode Therapeutics Inc

Jun 05 • 04:00PM ET

5.60

-0.24 -4.11 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: LNAI APRE BCDA BIVI CALC CVM GOVX KAPA KPRX NEUP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-48.65	Insider Own	9.08%	Shs Outstand	0.92M	Perf Week	8.95%
Market Cap	5.32M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	0.86M	Perf Month	-25.53%
Enterprise Value	135.75M	PEG	-	EPS next Q	-	Inst Own	3.25%	Short Float	4.22%	Perf Quarter	-41.67%
Income	-43.70M	P/S	-	EPS this Y	-	Inst Trans	2.61%	Short Ratio	0.76	Perf Half Y	-33.41%
Sales	0.00M	P/B	4.10	EPS next Y	-	ROA	-47.38%	Short Interest	0.04M	Perf YTD	-18.01%
Book/sh	1.36	P/C	0.41	EPS next 5Y	-	ROE	-52.14%	52W High	20.99 -73.32%	Perf Year	-22.44%
Cash/sh	13.52	P/FCF	-	EPS past 3/5Y	96.25% 79.17%	ROIC	-27.93%	52W Low	3.82 46.60%	Perf 3Y	-100.00%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	19.83% 13.04%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	95.40%	Oper. Margin	-	ATR (14)	0.73	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	3.11	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	38.71	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.11	EPS Q/Q	69.67%	SMA20	-6.92%	Beta	1.27	Target Price	280.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-25.23%	Rel Volume	2.09	Prev Close	5.84
Employees	12	LT Debt/Eq	0.00	Earnings	-	SMA200	-40.23%	Avg Volume	47.87K	Price	5.60
IPO	Jul 09, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	67.35% -100.00%	Trades		Volume	99,939	Change	-4.11%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)